Correlation Between Oncorus and Zura Bio
Can any of the company-specific risk be diversified away by investing in both Oncorus and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Zura Bio Limited, you can compare the effects of market volatilities on Oncorus and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Zura Bio.
Diversification Opportunities for Oncorus and Zura Bio
Pay attention - limited upside
The 3 months correlation between Oncorus and Zura is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Oncorus i.e., Oncorus and Zura Bio go up and down completely randomly.
Pair Corralation between Oncorus and Zura Bio
If you would invest (100.00) in Oncorus on December 3, 2024 and sell it today you would earn a total of 100.00 from holding Oncorus or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Oncorus vs. Zura Bio Limited
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Zura Bio Limited |
Oncorus and Zura Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Zura Bio
The main advantage of trading using opposite Oncorus and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Elevation Oncology |
Zura Bio vs. Highwoods Properties | Zura Bio vs. SNDL Inc | Zura Bio vs. Vita Coco | Zura Bio vs. Keurig Dr Pepper |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |